Zhigang Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zhigang Hu has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Xinyu Song
Department of Respiratory and Critical Care Medicine, The First College of Clinical Medical Science of China Three Gorges University, China Three Gorges University, Yichang, People’s Republic of China
12 shared publicationsYufeng Tian
Department of Teaching Office, Three Gorges University, Yichang, People’s Republic of China
9 shared publications- Xinyu Song
Department of Respiratory and Critical Care Medicine, The First College of Clinical Medicine Science, China Three Gorges University, Yichang, People’s Republic of China
7 shared publications Ailan Yang
Department of Respiratory and Critical Care Medicine, Yichang Central People’s Hospital at Zhijiang, Zhijiang, People’s Republic of China
6 shared publicationsFanjun Zeng
6 shared publications- Xinyu Song
Department of Respiratory and Critical Care Medicine, Affiliated Yichang Central People's Hospital of China Three Gorges University, Yichang, 443003, China.
4 shared publications
Latest Publications
- 3 September 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (10) , 927
Correction to: Behavioral speech therapy intervention can improve the postoperative pain and performance status of lung cancer patients undergoing thoracoscopic surgery
- 3 September 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (10) , 927
Correction to: Behavioral speech therapy intervention can improve the postoperative pain and performance status of lung cancer patients undergoing thoracoscopic surgery
- 18 August 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (9) , 864
Behavioral speech therapy intervention can improve the postoperative pain and performance status of lung cancer patients undergoing thoracoscopic surgery
Background Pain is common after lung surgery, yet non-pharmacological strategies remain underutilized. Behavioral Speech Therapy (BST) may improve recovery for thoracoscopic surgery patients. Purpose To evaluate whether BST reduces pain and improves physical function after thoracoscopic lung cancer surgery. Methods This secondary analysis of a registered trial (ChiCTR2400084313, originally evaluating BST for postoperative cough) used data from 112 patients who were assigned to routine care alone (control) or routine care plus BST (intervention). Pain (VAS, range 0–10 scores) and function (ECOG score, range 0–4 scores) were assessed at baseline (preoperative), 1 month, and 3 months postoperatively. All outcomes were evaluated by blinded assessors at three time points: preoperative (T0), 1 month post-surgery (T1), and 3 months post-surgery (T2). A mixed-effects model was used for analysis. Results At 1 month, the control group’s VAS worsened more than the BST group (MD -0.63, 95% CI: -1.07 to -0.19, P = 0.01) in Model 3. At 3 months, the between-group difference favored BST (MD -0.88, 95% CI: -1.32 to -0.44, P < 0.001). ECOG analysis showed a significant between-group difference at 1 month favoring BST (MD -0.27, 95% CI: -0.49 to -0.06, P = 0.01). The difference at 3 months was not statistically significant (MD -0.20, 95% CI: -0.42 to 0.01, P = 0.06). Conclusions BST reduces postoperative pain at 1 and 3 months and improves physical function at 1 month, suggesting its potential as a low-risk, non-pharmacological adjunct for pain management within enhanced recovery after surgery pathways.
- 18 August 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (9) , 864
Behavioral speech therapy intervention can improve the postoperative pain and performance status of lung cancer patients undergoing thoracoscopic surgery
Background Pain is common after lung surgery, yet non-pharmacological strategies remain underutilized. Behavioral Speech Therapy (BST) may improve recovery for thoracoscopic surgery patients. Purpose To evaluate whether BST reduces pain and improves physical function after thoracoscopic lung cancer surgery. Methods This secondary analysis of a registered trial (ChiCTR2400084313, originally evaluating BST for postoperative cough) used data from 112 patients who were assigned to routine care alone (control) or routine care plus BST (intervention). Pain (VAS, range 0–10 scores) and function (ECOG score, range 0–4 scores) were assessed at baseline (preoperative), 1 month, and 3 months postoperatively. All outcomes were evaluated by blinded assessors at three time points: preoperative (T0), 1 month post-surgery (T1), and 3 months post-surgery (T2). A mixed-effects model was used for analysis. Results At 1 month, the control group’s VAS worsened more than the BST group (MD -0.63, 95% CI: -1.07 to -0.19, P = 0.01) in Model 3. At 3 months, the between-group difference favored BST (MD -0.88, 95% CI: -1.32 to -0.44, P < 0.001). ECOG analysis showed a significant between-group difference at 1 month favoring BST (MD -0.27, 95% CI: -0.49 to -0.06, P = 0.01). The difference at 3 months was not statistically significant (MD -0.20, 95% CI: -0.42 to 0.01, P = 0.06). Conclusions BST reduces postoperative pain at 1 and 3 months and improves physical function at 1 month, suggesting its potential as a low-risk, non-pharmacological adjunct for pain management within enhanced recovery after surgery pathways.
- 31 July 2026
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 158 (4) , 1158-1159
First-trimester asthma controller medications and malformation risk: Bias, biologic plausibility, and unmeasured confounding
- 31 July 2026
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 158 (4) , 1158-1159
First-trimester asthma controller medications and malformation risk: Bias, biologic plausibility, and unmeasured confounding
- 6 May 2026
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 14 (5) , 1210-1211
Stepping up ICS doses in asthma: The crucial roles of relievers, triple therapy, and biomarkers
- 6 May 2026
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 14 (5) , 1210-1211
Stepping up ICS doses in asthma: The crucial roles of relievers, triple therapy, and biomarkers
- Open Access
- 27 April 2026
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 26 (1)
Pulmonary sarcoidosis with suspected bone marrow involvement presenting as severe thrombocytopenia: a case report
Sarcoidosis is a multisystem granulomatous disorder of unclear etiology, with the lungs and mediastinal lymph nodes being the most frequently involved site
- 27 April 2026
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 26 (1)
Open AccessPulmonary sarcoidosis with suspected bone marrow involvement presenting as severe thrombocytopenia: a case report
Sarcoidosis is a multisystem granulomatous disorder of unclear etiology, with the lungs and mediastinal lymph nodes being the most frequently involved site
- 19 December 2025
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (1) , 47
Effects of behavioural speech therapy on postoperative cough and cough-related quality of life of lung cancer patients undergoing thoracoscopic surgery: A prospective randomized controlled study
Background Behavioural speech therapy (BST) is a non-drug treatment for chronic cough. This study aimed to evaluate the impact of behavioural speech therapy based on the transtheoretical model on chronic cough and quality of life in lung cancer patients undergoing thoracoscopic surgery. Methods In this prospective randomized controlled trial, patients were randomly assigned 1:1 to receive either the BST intervention or standard care every 2 weeks for 3 months after surgery. The primary outcomes included the prevalence and severity of chronic cough; the secondary outcomes included cough-related quality of life, anxiety and depression. Data were collected at admission (T0), 1 month post-surgery (T1), and 3 months post-surgery (T2). A mixed-effects model was used to assess changes across time points and outcomes. The study was registered with the Chinese Clinical Trial Registration (ChiCTR2400084313; May 14, 2024). Results Between July and September 2024, we enrolled 112 patients for baseline assessment (57 patients in the intervention group and 55 patients in the control group). The prevalence of chronic cough was significantly lower in the intervention group than in the control group (21.1% vs. 43.6%, adjusted RR = 0.35, 95% CI: 0.19–0.64; P < 0.05). The mean difference in cough score was 4.11 (95% CI: -5.33 to -2.89; P < 0.001) lower in the BST group than in the control group from baseline to T2. The cough-related health scores of the intervention group were better than those of the control group in all dimensions after 1 month and 3 months. The mean differences in anxiety and depression in the BST group were greater than those in the control group from baseline to T2. Conclusions BST effectively decreases the prevalence of chronic cough, alleviates cough symptoms and improves quality of life.
- 19 December 2025
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (1) , 47
Effects of behavioural speech therapy on postoperative cough and cough-related quality of life of lung cancer patients undergoing thoracoscopic surgery: A prospective randomized controlled study
Background Behavioural speech therapy (BST) is a non-drug treatment for chronic cough. This study aimed to evaluate the impact of behavioural speech therapy based on the transtheoretical model on chronic cough and quality of life in lung cancer patients undergoing thoracoscopic surgery. Methods In this prospective randomized controlled trial, patients were randomly assigned 1:1 to receive either the BST intervention or standard care every 2 weeks for 3 months after surgery. The primary outcomes included the prevalence and severity of chronic cough; the secondary outcomes included cough-related quality of life, anxiety and depression. Data were collected at admission (T0), 1 month post-surgery (T1), and 3 months post-surgery (T2). A mixed-effects model was used to assess changes across time points and outcomes. The study was registered with the Chinese Clinical Trial Registration (ChiCTR2400084313; May 14, 2024). Results Between July and September 2024, we enrolled 112 patients for baseline assessment (57 patients in the intervention group and 55 patients in the control group). The prevalence of chronic cough was significantly lower in the intervention group than in the control group (21.1% vs. 43.6%, adjusted RR = 0.35, 95% CI: 0.19–0.64; P < 0.05). The mean difference in cough score was 4.11 (95% CI: -5.33 to -2.89; P < 0.001) lower in the BST group than in the control group from baseline to T2. The cough-related health scores of the intervention group were better than those of the control group in all dimensions after 1 month and 3 months. The mean differences in anxiety and depression in the BST group were greater than those in the control group from baseline to T2. Conclusions BST effectively decreases the prevalence of chronic cough, alleviates cough symptoms and improves quality of life.
- Open Access
- 31 October 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (44) , e45579
Association of weight-adjusted waist index and lung function in children and adolescents: A cross-sectional study from National Health and Nutrition Examination Survey (NHANES) 2007–2012
The negative impact of obesity on respiratory health has garnered widespread attention. As a novel obesity indicator, the weight-adjusted waist index (WWI) is the focus of our study, which aims to investigate the association between WWI and pulmonary function in U.S. children and adolescents. This cross-sectional study utilized data from the National Health and Nutrition Examination Survey spanning 2007 to 2012, focusing on participants with complete records of both WWI which is computed by dividing waist circumference by the square root of body weight. and pulmonary function measurements like forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), FEV1/FVC ratio, peak expiratory flow, and forced expiratory flow at 25% to 75% of FVC (FEF25%–75%). Multivariable regression and logistic regression analyses were conducted to assess the independent association between WWI and pulmonary function. Subgroup analyses and interaction tests were additionally performed. The study enrolled a total of 4237 participants. Those in higher WWI quartiles consistently demonstrated poorer pulmonary function metrics. In fully adjusted models, significant inverse associations were observed between WWI and multiple pulmonary function parameters, including FVC (β = ‐204.29, 95% CI: −231.79 to −176.80), FEV1 (β = ‐207.14, 95% CI: −230.78 to −183.51), FEV1/FVC ratio (β = −0.01, 95% CI: −0.01 to −0.01), peak expiratory flow (β = ‐430.92, 95% CI: −488.86 to −372.97), and forced expiratory flow at 25% to 75% of FVC (β = ‐252.78, 95% CI: −292.93 to −212.64). Participants in the highest WWI quartile exhibited significantly worse pulmonary function compared to those in the lowest quartile ( P for trend < .05). Subgroup analyses and interaction tests revealed stronger associations between WWI and pulmonary function impairment in male participants, non-Hispanic Whites, and individuals younger than 15 years. Our research indicates that higher WWI is associated with lower pulmonary function in children and adolescents, highlighting the importance of incorporating central obesity indicators into pediatric health assessments.
- 31 October 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (44) , e45579
Open AccessAssociation of weight-adjusted waist index and lung function in children and adolescents: A cross-sectional study from National Health and Nutrition Examination Survey (NHANES) 2007–2012
The negative impact of obesity on respiratory health has garnered widespread attention. As a novel obesity indicator, the weight-adjusted waist index (WWI) is the focus of our study, which aims to investigate the association between WWI and pulmonary function in U.S. children and adolescents. This cross-sectional study utilized data from the National Health and Nutrition Examination Survey spanning 2007 to 2012, focusing on participants with complete records of both WWI which is computed by dividing waist circumference by the square root of body weight. and pulmonary function measurements like forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), FEV1/FVC ratio, peak expiratory flow, and forced expiratory flow at 25% to 75% of FVC (FEF25%–75%). Multivariable regression and logistic regression analyses were conducted to assess the independent association between WWI and pulmonary function. Subgroup analyses and interaction tests were additionally performed. The study enrolled a total of 4237 participants. Those in higher WWI quartiles consistently demonstrated poorer pulmonary function metrics. In fully adjusted models, significant inverse associations were observed between WWI and multiple pulmonary function parameters, including FVC (β = ‐204.29, 95% CI: −231.79 to −176.80), FEV1 (β = ‐207.14, 95% CI: −230.78 to −183.51), FEV1/FVC ratio (β = −0.01, 95% CI: −0.01 to −0.01), peak expiratory flow (β = ‐430.92, 95% CI: −488.86 to −372.97), and forced expiratory flow at 25% to 75% of FVC (β = ‐252.78, 95% CI: −292.93 to −212.64). Participants in the highest WWI quartile exhibited significantly worse pulmonary function compared to those in the lowest quartile ( P for trend < .05). Subgroup analyses and interaction tests revealed stronger associations between WWI and pulmonary function impairment in male participants, non-Hispanic Whites, and individuals younger than 15 years. Our research indicates that higher WWI is associated with lower pulmonary function in children and adolescents, highlighting the importance of incorporating central obesity indicators into pediatric health assessments.
- Open Access
- 29 October 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-10
High sodium intake increases interstitial lung disease and pulmonary sarcoidosis based on the Global Burden of Disease study 1999–2019
This study investigated the relationships between dietary sodium intake and the incidence and prevalence of interstitial lung disease (ILD) and pulmonary sarcoidosis using data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2019. This study assessed the strength of the abovementioned relationships via LASSO analysis and a generalized additive model with Poisson regression and determined the nonlinear and lagged effects via a distributed lag nonlinear model (DLNM). In the past three decades, global dietary sodium intake has decreased gradually. Two LASSO and generalized additive analyses both suggested that dietary sodium intake is obviously correlated with the incidence and prevalence of ILD and pulmonary sarcoidosis. The overall exposure‒response curve revealed a dose‒effect relationship between dietary sodium intake and the incidence and prevalence of ILD and pulmonary sarcoidosis. The maximum lag-specific RR of extremely high dietary sodium intake was 1.75 (95% CI: 1.61–1.91, lag 0 year) for incidence and 3.19 (95% CI: 2.24–4.53, lag 0 year) for prevalence relative to the reference. Our study suggests that dietary sodium intake is positively associated with the incidence and prevalence of ILD and pulmonary sarcoidosis. These findings may have important policy implications for dietary sodium intake-reduction strategies to decrease the burden of respiratory diseases and promote public health.
- 29 October 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-10
Open AccessHigh sodium intake increases interstitial lung disease and pulmonary sarcoidosis based on the Global Burden of Disease study 1999–2019
This study investigated the relationships between dietary sodium intake and the incidence and prevalence of interstitial lung disease (ILD) and pulmonary sarcoidosis using data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2019. This study assessed the strength of the abovementioned relationships via LASSO analysis and a generalized additive model with Poisson regression and determined the nonlinear and lagged effects via a distributed lag nonlinear model (DLNM). In the past three decades, global dietary sodium intake has decreased gradually. Two LASSO and generalized additive analyses both suggested that dietary sodium intake is obviously correlated with the incidence and prevalence of ILD and pulmonary sarcoidosis. The overall exposure‒response curve revealed a dose‒effect relationship between dietary sodium intake and the incidence and prevalence of ILD and pulmonary sarcoidosis. The maximum lag-specific RR of extremely high dietary sodium intake was 1.75 (95% CI: 1.61–1.91, lag 0 year) for incidence and 3.19 (95% CI: 2.24–4.53, lag 0 year) for prevalence relative to the reference. Our study suggests that dietary sodium intake is positively associated with the incidence and prevalence of ILD and pulmonary sarcoidosis. These findings may have important policy implications for dietary sodium intake-reduction strategies to decrease the burden of respiratory diseases and promote public health.
- 7 August 2023
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 11 (8) , 2625-2626
Importance of periodic sleep monitoring in asthma management
- 7 August 2023
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 11 (8) , 2625-2626
Importance of periodic sleep monitoring in asthma management
- Open Access
- 13 July 2023
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 14 (5) , 2029-2043
Associations between indoor air pollution for cooking and heating with muscle and sarcopenia in Chinese older population
Background: Exposure to air pollution brings the advent effect for various diseases, but study about the relationship between air pollution and ageing is scant. We aimed to determine the associations between household air pollution for cooking and heating with muscle and sarcopenia in Chinese older population by a nationally representative study.Methods: This cross‐sectional study included individuals aged 60 and above from the China Health and Retirement Longitudinal Study between 2011 and 2015. The diagnosis of sarcopenia was defined by low muscle mass with low muscle strength and/or reduced physical performance. Generalized additive analyses and dose‐dependent analyses with three models were used to assess the effects of different pattern of cooking and heating on muscle and sarcopenia.Results: A total of 8126 Chinese older individuals with predominant male (53.7%) and mean age of 67.3 ± 6.0 years were included in our study. Solid fuel use in cooking showed significant declines in muscle strength (β = −0.424, 95% CI: −0.767, −0.082, P = 0.01 in model 3) and mass (β = −0.034, 95% CI: −0.051, −0.017, P < 0.01 in model 3), when compared with clean fuel use in cooking, respectively. Solid fuel for heating was correlated with lower muscle strength (β = −0.637, 95% CI: −1.033, −0.241, P < 0.01 in model 3) than clean fuel for heating. The joint use of solid fuel for cooking and heating was associated with reduced muscle strength (β = −0.835, 95% CI: −1.306, −0.365, P < 0.01 in model 3) and mass (β = −0.038, 95% CI: −0.061, −0.015, P < 0.01 in model 3) than clean fuel for cooking and heating. Solid fuel for cooking was associated with significantly increased risk of low muscle strength (adjusted OR = 1.29, 95% CI: 1.11, 1.50, P < 0.01 in model 3) and mass (adjusted OR = 1.35, 95% CI: 1.11, 1.61, P < 0.01 in model 3), possible sarcopenia (adjusted OR = 1.33, 95% CI: 1.19, 1.48, P < 0.01 in model 3) and sarcopenia (adjusted OR = 1.44, 95% CI: 1.21, 1.72, P < 0.01 in model 3) compared with clean fuel for cooking. Solid fuel for heating had a significant correlation with low muscle strength (adjusted OR = 1.30, 95% CI: 1.09, 1.56, P < 0.01 in model 3) and possible sarcopenia (adjusted OR = 1.49, 95% CI: 1.31, 1.70, P < 0.01 in model 3). Dose‐dependent manner was shown in the associations between the number of solid fuel with low muscle strength and possible sarcopenia. Clean fuel for cooking and solid fuel for heating was positively associated with the prevalence of possible sarcopenia than clean fuel for cooking and heating (adjusted OR = 1.34, 95% CI: 1.14, 1.57, P < 0.01 in model 3).Conclusions: Our findings suggested that solid fuel for cooking and the number of solid fuel use potentially facilitates the onset and progression of muscle loss and sarcopenia.
- 13 July 2023
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 14 (5) , 2029-2043
Open AccessAssociations between indoor air pollution for cooking and heating with muscle and sarcopenia in Chinese older population
Background: Exposure to air pollution brings the advent effect for various diseases, but study about the relationship between air pollution and ageing is scant. We aimed to determine the associations between household air pollution for cooking and heating with muscle and sarcopenia in Chinese older population by a nationally representative study.Methods: This cross‐sectional study included individuals aged 60 and above from the China Health and Retirement Longitudinal Study between 2011 and 2015. The diagnosis of sarcopenia was defined by low muscle mass with low muscle strength and/or reduced physical performance. Generalized additive analyses and dose‐dependent analyses with three models were used to assess the effects of different pattern of cooking and heating on muscle and sarcopenia.Results: A total of 8126 Chinese older individuals with predominant male (53.7%) and mean age of 67.3 ± 6.0 years were included in our study. Solid fuel use in cooking showed significant declines in muscle strength (β = −0.424, 95% CI: −0.767, −0.082, P = 0.01 in model 3) and mass (β = −0.034, 95% CI: −0.051, −0.017, P < 0.01 in model 3), when compared with clean fuel use in cooking, respectively. Solid fuel for heating was correlated with lower muscle strength (β = −0.637, 95% CI: −1.033, −0.241, P < 0.01 in model 3) than clean fuel for heating. The joint use of solid fuel for cooking and heating was associated with reduced muscle strength (β = −0.835, 95% CI: −1.306, −0.365, P < 0.01 in model 3) and mass (β = −0.038, 95% CI: −0.061, −0.015, P < 0.01 in model 3) than clean fuel for cooking and heating. Solid fuel for cooking was associated with significantly increased risk of low muscle strength (adjusted OR = 1.29, 95% CI: 1.11, 1.50, P < 0.01 in model 3) and mass (adjusted OR = 1.35, 95% CI: 1.11, 1.61, P < 0.01 in model 3), possible sarcopenia (adjusted OR = 1.33, 95% CI: 1.19, 1.48, P < 0.01 in model 3) and sarcopenia (adjusted OR = 1.44, 95% CI: 1.21, 1.72, P < 0.01 in model 3) compared with clean fuel for cooking. Solid fuel for heating had a significant correlation with low muscle strength (adjusted OR = 1.30, 95% CI: 1.09, 1.56, P < 0.01 in model 3) and possible sarcopenia (adjusted OR = 1.49, 95% CI: 1.31, 1.70, P < 0.01 in model 3). Dose‐dependent manner was shown in the associations between the number of solid fuel with low muscle strength and possible sarcopenia. Clean fuel for cooking and solid fuel for heating was positively associated with the prevalence of possible sarcopenia than clean fuel for cooking and heating (adjusted OR = 1.34, 95% CI: 1.14, 1.57, P < 0.01 in model 3).Conclusions: Our findings suggested that solid fuel for cooking and the number of solid fuel use potentially facilitates the onset and progression of muscle loss and sarcopenia.